Clinical Trial Update: Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by a Donor Stem Cell Transplant in Treating Patients With Immunodeficiency or Other Nonmalignant Inherited Disorders [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating alemtuzumab, fludarabine phosphate, and total-body irradiation followed by donor stem cell transplant for immunodeficiency or nonmalign…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunodeficiency Syndrome
• Non-cancer Diagnosis

Drugs mentioned

• Alemtuzumab (Alemtuzumab)
• Donor stem cell transplant
• Fludarabine phosphate (Fludarabine phosphate)
• Total Body Irradiation

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Immunodeficiency Syndrome, Non-Cancer Diagnosis | Phase 2 | Status: COMPLETED | Results posted: 2017-05-19